Markets:

Overview

News

Currencies

International

Treasuries

Bank of America (NY:BAC)

50.72 +0.95 (+1.90%)

Streaming Delayed Price Updated: 1:36 PM EDT, May 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bank of America

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

3 Energy Stocks That Are Quietly Becoming the Trades of the Year ↗

Today 10:05 EDT

These energy stocks are surging amid skyrocketing power demand and ongoing geopolitical conflicts that have disrupted oil and gas markets.

Via The Motley Fool

Topics Supply Chain

J.B. Hunt Says Freight Rates Are Rising as Capacity Tightens, Not Demand ↗

Today 8:05 EDT

Executives from J.B. Hunt Transport Services (NASDAQ:JBHT) said freight-market conditions are tightening, but they attributed much of the shift to capacity leaving the market rather than a broad-based...

Via MarketBeat

Topics Artificial Intelligence

Should You Forget Ripple and Buy This Nuclear Stock Instead? ↗

Today 7:25 EDT

Ripple is promising, but nuclear stocks could be a better bargain.

Via The Motley Fool

Topics Artificial Intelligence Energy

Best Bank Stocks to Buy in 2026 ↗

Today 4:13 EDT

With credit conditions potentially worsening in the second half of the year, look for a flight to safety.

Via The Motley Fool

Topics Economy

Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus ↗

Today 3:03 EDT

Insmed (NASDAQ:INSM) Chair and CEO Will Lewis said the company remains confident in the launch trajectory of BRINSUPRI, despite investor concerns over discontinuation rates that followed the company’s...

Via MarketBeat

2 Nuclear Energy Stocks to Buy in May ↗

Today 2:25 EDT

Nuclear energy could grow into a $10 trillion industry in the next 25 years. For investors who are bullish on nuclear, these two stocks are absolute buys.

Via The Motley Fool

Topics Artificial Intelligence Supply Chain

Incyte CEO Says Post-Jakafi Growth Path Is Clearer as Pipeline Catalysts Build ↗

Today 1:10 EDT

Incyte (NASDAQ:INCY) President and CEO Bill Meury said the company’s post-Jakafi growth profile has become “much clearer” over the past year, pointing to continued growth in its commercial business,...

Via MarketBeat

IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data ↗

Today 0:05 EDT

IDEAYA Biosciences (NASDAQ:IDYA) said its lead oncology program remains on track for a regulatory submission after reporting positive top-line data in first-line metastatic melanoma, while also...

Via MarketBeat

Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears ↗

May 17, 2026

Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief executive officer, Chief Financial Officer...

Via MarketBeat

Topics Economy

Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness ↗

May 17, 2026

Henry Schein (NASDAQ:HSIC) executives said the company is seeing continued momentum in its dental business and remains committed to previously outlined operating improvement targets, while...

Via MarketBeat

Topics Artificial Intelligence Supply Chain

GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead ↗

May 17, 2026

GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related to its NHS study, according to comments made by Aaron, who...

Via MarketBeat

Citigroup's Quiet Turnaround: Is the Stock Finally Worth Buying? ↗

May 17, 2026

Shares of Citigroup have risen by more than 60% over the past year, trouncing the performance of many peers.

Via The Motley Fool

Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline ↗

May 17, 2026

Gilead Sciences (NASDAQ:GILD) Chief Commercial Officer and Head of Corporate Affairs Johanna Mercier said the company is leaning on its HIV business while continuing to build out oncology and...

Via MarketBeat

GE HealthCare Technologies Sticks to Growth Story After Inflation-Driven Guidance Cut ↗

May 17, 2026

GE HealthCare Technologies (NASDAQ:GEHC) executives said the company remains confident in its long-term growth prospects despite a disappointing first quarter that led to a reduction in full-year...

Via MarketBeat

Analyst Predicts Nvidia Stock Should Be 42% Higher ↗

May 16, 2026

Nvidia is well-positioned to continue shaping the future of artificial intelligence.

Via The Motley Fool

Topics Artificial Intelligence

4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy ↗

May 16, 2026

4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage...

Via MarketBeat

Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference ↗

May 16, 2026

Erasca (NASDAQ:ERAS) executives said the company sees multiple potential development paths for its RAS-targeting portfolio, highlighting early clinical activity for ERAS-0015 in lung, pancreatic and...

Via MarketBeat

Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification ↗

May 16, 2026

Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and...

Via MarketBeat

Denali Therapeutics Says AVLAYAH Launch Ahead of Expectations After Hunter Syndrome Approval ↗

May 16, 2026

Denali Therapeutics (NASDAQ:DNLI) is seeing early commercial interest for its first approved drug, AVLAYAH, following its March 24 accelerated approval for Hunter syndrome, Chief Operating Officer and...

Via MarketBeat

CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms ↗

May 15, 2026

CRISPR Therapeutics (NASDAQ:CRSP) Chief Executive Officer Sam Kulkarni said the company is entering a “second phase” as it moves beyond the initial launch of CASGEVY and prepares for data from multiple...

Via MarketBeat

Topics Intellectual Property

Akamai Stock Is Surging on an Analyst Upgrade. It’s No Longer a Legacy Tech Company.

May 15, 2026

Akamai stock is soaring as Bank of America says the company is rapidly emerging as a major AI infrastructure player, boosting its price target to $175.

Via Barchart.com

Topics Artificial Intelligence

Why Bank of America Could Be the Best Value Among the Big Banks Right Now ↗

May 15, 2026

Bank of America is one of Warren Buffett's favorite stocks.

Via The Motley Fool

Here's What the Latest Inflation Data Could Mean for Crypto ↗

May 15, 2026

This bearish inflation report could rain on the parade when it's just getting restarted.

Via The Motley Fool

Topics Economy

Click n’ Close expands Whole Loan Trading division with engagement of Christy Soukhamneut and Launch Point Advisory Group

May 15, 2026

ADDISON, Texas, May 15, 2026 (SEND2PRESS NEWSWIRE) -- Click n' Close, a multi-state mortgage lender, announced strategic engagement of Christy Soukhamneut and Launch Point Advisory Group to support the...

Via Send2Press

CG Oncology BLA Filing on Track as Key Bladder Cancer Data Nears ↗

May 15, 2026

CG Oncology (NASDAQ:CGON) executives said the company remains on track to complete a rolling biologics license application for cretostimogene in BCG-unresponsive high-risk non-muscle invasive bladder...

Via MarketBeat

Topics Initial Public Offering

CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records ↗

May 15, 2026

CeriBell (NASDAQ:CBLL) executives said the company’s first-quarter results reflected continued momentum in both new account additions and increased usage among existing hospital customers, while...

Via MarketBeat

1 Mega-Cap Stock to Own for Decades and 2 We Turn Down

May 15, 2026

Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less roo...

Via StockStory

Biogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology Push ↗

May 14, 2026

Biogen (NASDAQ:BIIB) is continuing to position immunology as a larger part of its strategy, with late-stage lupus and kidney disease programs expected to shape the company’s next phase of growth, Adam...

Via MarketBeat

Bicara Therapeutics Touts Cancer Drug Progress Ahead of 2026 Pivotal Data ↗

May 14, 2026

Bicara Therapeutics (NASDAQ:BCAX) said its lead cancer drug candidate, ficerafusp alfa, remains on track for pivotal data in head and neck cancer in mid-2026, as the company outlined its development...

Via MarketBeat

Why Nvidia (NVDA) Stock Is Trading Up Today

May 14, 2026

What Happened? Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA) jumped 3.7% in the afternoon session after a Reuters report indicated the US...

Via StockStory

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Bank of America (NY:BAC)

All News about Bank of America

Starting at $3.75/week.

Subscribe Today